Olivier Sitbon, MD, PhD, reviews PDGF-targeted therapy in PAH, from imatinib's IMPRES trial to new prodrug and antibody approaches.
Olivier Sitbon, MD, PhD
Advertisement
Professor of Respiratory Medicine at Université Paris-Saclay
Articles by Olivier Sitbon, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
Alpha-Gal Syndrome: Closing an Underrecognized Allergy Diagnostic Gap
2
ORFAN-MAESTRIA: AI Predicts Cardioembolic Stroke, Atrial Fibrillation from CT Scans
3
GRI-0621 Improves FVC, Reduces Fibrotic Biomarkers in IPF
4
Pelacarsen Misses Primary Endpoint in Lp(a)HORIZON Phase 3 Trial
5